These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36615760)

  • 21. Muscle NAD
    Hulmi JJ; Penna F; Pöllänen N; Nissinen TA; Hentilä J; Euro L; Lautaoja JH; Ballarò R; Soliymani R; Baumann M; Ritvos O; Pirinen E; Lalowski M
    Mol Metab; 2020 Nov; 41():101046. PubMed ID: 32599075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colon 26 adenocarcinoma (C26)-induced cancer cachexia impairs skeletal muscle mitochondrial function and content.
    Neyroud D; Nosacka RL; Judge AR; Hepple RT
    J Muscle Res Cell Motil; 2019 Mar; 40(1):59-65. PubMed ID: 30945134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs.
    Barreto R; Waning DL; Gao H; Liu Y; Zimmers TA; Bonetto A
    Oncotarget; 2016 Jul; 7(28):43442-43460. PubMed ID: 27259276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia.
    Ham DJ; Murphy KT; Chee A; Lynch GS; Koopman R
    Clin Nutr; 2014 Jun; 33(3):448-58. PubMed ID: 23835111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myostatin is a novel tumoral factor that induces cancer cachexia.
    Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
    Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skeletal muscle atrophy and dysfunction in breast cancer patients: role for chemotherapy-derived oxidant stress.
    Guigni BA; Callahan DM; Tourville TW; Miller MS; Fiske B; Voigt T; Korwin-Mihavics B; Anathy V; Dittus K; Toth MJ
    Am J Physiol Cell Physiol; 2018 Nov; 315(5):C744-C756. PubMed ID: 30207784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin-6 dependent.
    Reddel CJ; Allen JD; Ehteda A; Taylor R; Chen VM; Curnow JL; Kritharides L; Robertson G
    J Thromb Haemost; 2017 Mar; 15(3):477-486. PubMed ID: 28058802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors.
    Villars FO; Pietra C; Giuliano C; Lutz TA; Riediger T
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher skeletal muscle protein synthesis and lower breakdown after chemotherapy in cachectic mice.
    Samuels SE; Knowles AL; Tilignac T; Debiton E; Madelmont JC; Attaix D
    Am J Physiol Regul Integr Comp Physiol; 2001 Jul; 281(1):R133-9. PubMed ID: 11404286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a traditional Chinese medicine-based agent for the treatment of cancer cachexia.
    Wu KC; Chu PC; Cheng YJ; Li CI; Tian J; Wu HY; Wu SH; Lai YC; Kao HH; Hsu AL; Lin HW; Lin CH
    J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2073-2087. PubMed ID: 35718751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
    Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X
    Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Mitochondria-Targeting Agent MitoQ Improves Muscle Atrophy, Weakness and Oxidative Metabolism in C26 Tumor-Bearing Mice.
    Pin F; Huot JR; Bonetto A
    Front Cell Dev Biol; 2022; 10():861622. PubMed ID: 35392166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skeletal muscle mitochondrial uncoupling in a murine cancer cachexia model.
    Tzika AA; Fontes-Oliveira CC; Shestov AA; Constantinou C; Psychogios N; Righi V; Mintzopoulos D; Busquets S; Lopez-Soriano FJ; Milot S; Lepine F; Mindrinos MN; Rahme LG; Argiles JM
    Int J Oncol; 2013 Sep; 43(3):886-94. PubMed ID: 23817738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting Mitochondria by SS-31 Ameliorates the Whole Body Energy Status in Cancer- and Chemotherapy-Induced Cachexia.
    Ballarò R; Lopalco P; Audrito V; Beltrà M; Pin F; Angelini R; Costelli P; Corcelli A; Bonetto A; Szeto HH; O'Connell TM; Penna F
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670497
    [No Abstract]   [Full Text] [Related]  

  • 35. Muscle oxidative capacity during IL-6-dependent cancer cachexia.
    White JP; Baltgalvis KA; Puppa MJ; Sato S; Baynes JW; Carson JA
    Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R201-11. PubMed ID: 21148472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Creatine modulates cellular energy metabolism and protects against cancer cachexia-associated muscle wasting.
    Wei L; Wang R; Lin K; Jin X; Li L; Wazir J; Pu W; Lian P; Lu R; Song S; Zhao Q; Li J; Wang H
    Front Pharmacol; 2022; 13():1086662. PubMed ID: 36569317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of chemotherapy through reducing of cachexia by using Citrus unshiu peel extract.
    Tahaghoghi-Hajghorbani S; Ebrahimzadeh MA; Rafiei A; Golpour M; Hosseini-Khah Z; Akhtari J
    J Ethnopharmacol; 2019 Oct; 242():111929. PubMed ID: 31054317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice.
    Berardi E; Aulino P; Murfuni I; Toschi A; Padula F; Scicchitano BM; Coletti D; Adamo S
    Neurol Res; 2008 Mar; 30(2):160-9. PubMed ID: 18397608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse.
    White JP; Puppa MJ; Sato S; Gao S; Price RL; Baynes JW; Kostek MC; Matesic LE; Carson JA
    Skelet Muscle; 2012 Jul; 2():14. PubMed ID: 22769563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metronomic 5-Fluorouracil Delivery Primes Skeletal Muscle for Myopathy but Does Not Cause Cachexia.
    Campelj DG; Timpani CA; Cree T; Petersen AC; Hayes A; Goodman CA; Rybalka E
    Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34067869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.